Author’s reply to ‘Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy’

Taizo Uchimoto; Kensuke Hirosuna; Heima Niigawa; Taisuke Jo; Hirofumi Morinaka; Wataru Fukuokaya; Atsuhiko Yoshizawa; Masanobu Saruta; Tsuyoshi Morita; Saizo Fujimoto; Yutaka Yamamoto; Moritoshi Sakamoto; Kazuki Nishimura; Ryoichi Maenosono; Takuya Tsujino; Kyosuke Nishio; Yuki Yoshikawa; Atsushi Ichihashi; Fumihiko Urabe; Keiichiro Mori; Takafumi Yanagisawa; Shunsuke Tsuzuki; Kiyoshi Takahara; Teruo Inamoto; Kazutoshi Fujita; Haruhito Azuma; Takahiro Kimura; Kazumasa Komura

doi:10.1093/jjco/hyag059

Author’s reply to ‘Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy’

Taizo Uchimoto
, Kensuke Hirosuna
, Heima Niigawa
, Taisuke Jo
, Hirofumi Morinaka
, Wataru Fukuokaya
, Atsuhiko Yoshizawa
, Masanobu Saruta
, Tsuyoshi Morita
, Saizo Fujimoto
, Yutaka Yamamoto
, Moritoshi Sakamoto
, Kazuki Nishimura
, Ryoichi Maenosono
, Takuya Tsujino
, Kyosuke Nishio
, Yuki Yoshikawa
, Atsushi Ichihashi
, Fumihiko Urabe
, Keiichiro Mori

Takafumi Yanagisawa, Shunsuke Tsuzuki, Kiyoshi Takahara, Teruo Inamoto, Kazutoshi Fujita, Haruhito Azuma, Takahiro Kimura, Kazumasa Komura

医学部・腎泌尿器外科学

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	1024
ページ数	1
ジャーナル	Japanese journal of clinical oncology
巻	56
号	8
DOI	https://doi.org/10.1093/jjco/hyag059
出版ステータス	出版済み - 08-2026

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

腫瘍学
放射線学、核医学およびイメージング
癌研究

文献へのアクセス

10.1093/jjco/hyag059

他のファイルとリンク

引用スタイル

Uchimoto, T., Hirosuna, K., Niigawa, H., Jo, T., Morinaka, H., Fukuokaya, W., Yoshizawa, A., Saruta, M., Morita, T., Fujimoto, S., Yamamoto, Y., Sakamoto, M., Nishimura, K., Maenosono, R., Tsujino, T., Nishio, K., Yoshikawa, Y., Ichihashi, A., Urabe, F., ... Komura, K. (2026). Author’s reply to ‘Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy’. Japanese journal of clinical oncology, 56(8), 1024. https://doi.org/10.1093/jjco/hyag059

@article{f90a4f48910c466198e6151b402320c2,

title = "Author{\textquoteright}s reply to {\textquoteleft}Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy{\textquoteright}",

author = "Taizo Uchimoto and Kensuke Hirosuna and Heima Niigawa and Taisuke Jo and Hirofumi Morinaka and Wataru Fukuokaya and Atsuhiko Yoshizawa and Masanobu Saruta and Tsuyoshi Morita and Saizo Fujimoto and Yutaka Yamamoto and Moritoshi Sakamoto and Kazuki Nishimura and Ryoichi Maenosono and Takuya Tsujino and Kyosuke Nishio and Yuki Yoshikawa and Atsushi Ichihashi and Fumihiko Urabe and Keiichiro Mori and Takafumi Yanagisawa and Shunsuke Tsuzuki and Kiyoshi Takahara and Teruo Inamoto and Kazutoshi Fujita and Haruhito Azuma and Takahiro Kimura and Kazumasa Komura",

year = "2026",

month = aug,

doi = "10.1093/jjco/hyag059",

language = "English",

volume = "56",

pages = "1024",

journal = "Japanese journal of clinical oncology",

issn = "0368-2811",

publisher = "Oxford University Press",

number = "8",

}

Uchimoto, T, Hirosuna, K, Niigawa, H, Jo, T, Morinaka, H, Fukuokaya, W, Yoshizawa, A , Saruta, M, Morita, T, Fujimoto, S, Yamamoto, Y, Sakamoto, M, Nishimura, K, Maenosono, R, Tsujino, T, Nishio, K, Yoshikawa, Y, Ichihashi, A, Urabe, F, Mori, K, Yanagisawa, T, Tsuzuki, S, Takahara, K, Inamoto, T, Fujita, K, Azuma, H, Kimura, T & Komura, K 2026, 'Author’s reply to ‘Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy’', Japanese journal of clinical oncology, vol. 56, no. 8, pp. 1024. https://doi.org/10.1093/jjco/hyag059

TY - JOUR

T1 - Author’s reply to ‘Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy’

AU - Uchimoto, Taizo

AU - Hirosuna, Kensuke

AU - Niigawa, Heima

AU - Jo, Taisuke

AU - Morinaka, Hirofumi

AU - Fukuokaya, Wataru

AU - Yoshizawa, Atsuhiko

AU - Saruta, Masanobu

AU - Morita, Tsuyoshi

AU - Fujimoto, Saizo

AU - Yamamoto, Yutaka

AU - Sakamoto, Moritoshi

AU - Nishimura, Kazuki

AU - Maenosono, Ryoichi

AU - Tsujino, Takuya

AU - Nishio, Kyosuke

AU - Yoshikawa, Yuki

AU - Ichihashi, Atsushi

AU - Urabe, Fumihiko

AU - Mori, Keiichiro

AU - Yanagisawa, Takafumi

AU - Tsuzuki, Shunsuke

AU - Takahara, Kiyoshi

AU - Inamoto, Teruo

AU - Fujita, Kazutoshi

AU - Azuma, Haruhito

AU - Kimura, Takahiro

AU - Komura, Kazumasa

PY - 2026/8

Y1 - 2026/8

UR - https://www.scopus.com/pages/publications/105046499626

UR - https://www.scopus.com/pages/publications/105046499626#tab=citedBy

U2 - 10.1093/jjco/hyag059

DO - 10.1093/jjco/hyag059

M3 - Letter

C2 - 42003254

AN - SCOPUS:105046499626

SN - 0368-2811

VL - 56

SP - 1024

JO - Japanese journal of clinical oncology

JF - Japanese journal of clinical oncology

IS - 8

ER -